I-124 PET/CT Imaging for Thyroid Cancer
Part of Cancer, Hormones & metabolism clinical trials.
This study uses a special type of PET/CT scan (I-124) to see where thyroid cancer is in your body and how much radiation it would get from radioactive iodine therapy. It helps doctors plan treatment for people whose cancer may not respond to standard radioactive iodine or who are being considered for targeted medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had your entire thyroid removed (total thyroidectomy).
- Your thyroid cancer has come back or spread to lymph nodes or other parts of the body.
- You are 18 or older.
- You are expected to live more than 3 months.
- You are able to walk and take care of yourself (ECOG score 0–2).
- You are not pregnant or nursing (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new type of scan (I-124 PET/CT) can better detect thyroid cancer compared to standard scans. It may help doctors decide on the best treatment, such as radiation therapy or surgery.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
This trial tests a new type of PET scan (F-18 Tetrafluoroborate) to find thyroid cancer cells that don't show up on standard scans. It's for people who have had surgery and radioactive iodine therapy but still have signs of cancer in their blood tests.
This study tests a new type of PET scan to find thyroid cancer that has come back or spread. It compares two tracers to see which one better shows the cancer, which may help doctors choose the right treatment.
This study looks at how well radioactive iodine therapy works for patients with certain types of thyroid cancer that are considered low or intermediate risk. It may help you understand if this treatment is right for you.
This trial tests a special PET scan (68Ga-FAPI) to see if it can better find thyroid cancer that has come back or spread after surgery. It may help your doctor decide on the best next steps for your care.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.